These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 2414981)

  • 1. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-cross-resistant sequential combination chemotherapy consisting of cis-diammine-dichloroplatinum (II) mainly, based on synchronization theory, in human bladder cancer xenografts in athymic nude mice].
    Yamauchi T; Okada K; Yoshida O
    Hinyokika Kiyo; 1986 Dec; 32(12):1781-97. PubMed ID: 2435129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S; Ito T; Aizawa T; Namiki K; Ohno Y; Yamamoto S; Ishibashi K; Miki M; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
    Okada K; Kanamaru H; Yoshiki T; Hashimura T; Nishimura K; Hida S; Nishio Y; Oishi K; Yoshida O; Yamauchi T
    Hinyokika Kiyo; 1988 Nov; 34(11):1911-6. PubMed ID: 2468265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O; Yoshimura N; Taniguchi T; Nishimura K; Nakagawa T
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H; Tada Y; Nakano E; Matsuda M; Osafune M; Sagawa S; Takaha M; Sonoda T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hashimura T; Okumura K; Akao T; Nakagawa T
    Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I; Kawabe Y; Nakashima T; Yamagiwa M; Suzuki T; Mizuno A; Mineda H
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2567-78. PubMed ID: 1702133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
    Fujihiro S; Takeuchi T; Fujimoto Y; Okano M; Horie M; Kanematsu M; Kuriyama M; Ban Y; Nishiura T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):427-32. PubMed ID: 6200077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of multidisciplinary treatment involving chemotherapy with cis-diamminedichloroplatinum, bleomycin (peplomycin) and 5-fluorouracil for advanced esophageal carcinoma].
    Nakamura J; Nasu H; Masamune O; Inoue Y
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):939-45. PubMed ID: 1697321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
    Kubota Y; Shuin T; Miura T; Moriyama M; Fukushima S; Shiozaki H; Ooshima H
    Cancer Treat Rep; 1984 Sep; 68(9):1167-8. PubMed ID: 6206946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy with bleomycin, vinca alkaloid and cisplatin (BVP) for advanced urothelial cancer].
    Sekine H; Fukui I; Yamada T; Takeuchi S; Tachibana Y; Yokokawa M
    Hinyokika Kiyo; 1984 Aug; 30(8):1095-9. PubMed ID: 6083719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on a neo-adjuvant chemotherapy for head and neck cancer].
    Inuyama Y; Mashino S; Fujii M; Tanaka J; Takaoka T; Kohno N; Horiuchi M
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):786-91. PubMed ID: 6192768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T; Sakaguchi H; Kajikawa H; Nishioka T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.